J. Grossman, Jaymin Patel, Bonnie L. Bullock, B. Morin, Lilian Gaynor, Manuel Hidalgo, B. Bockorny
{"title":"AGEN1423是一种抗cd73 - tgf β- trap双功能抗体,在晚期胰腺癌患者中与balstilimumab联合化疗或不化疗的651期2期试验","authors":"J. Grossman, Jaymin Patel, Bonnie L. Bullock, B. Morin, Lilian Gaynor, Manuel Hidalgo, B. Bockorny","doi":"10.1136/jitc-2022-sitc2022.0651","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":398566,"journal":{"name":"Regular and Young Investigator Award Abstracts","volume":"83 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"651 Phase 2 trial of AGEN1423, an anti-CD73-TGFβ-Trap bifunctional antibody, in combination with balstilimab, with or without chemotherapy in subjects with advanced pancreatic cancer\",\"authors\":\"J. Grossman, Jaymin Patel, Bonnie L. Bullock, B. Morin, Lilian Gaynor, Manuel Hidalgo, B. Bockorny\",\"doi\":\"10.1136/jitc-2022-sitc2022.0651\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":398566,\"journal\":{\"name\":\"Regular and Young Investigator Award Abstracts\",\"volume\":\"83 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Regular and Young Investigator Award Abstracts\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/jitc-2022-sitc2022.0651\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Regular and Young Investigator Award Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/jitc-2022-sitc2022.0651","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
651 Phase 2 trial of AGEN1423, an anti-CD73-TGFβ-Trap bifunctional antibody, in combination with balstilimab, with or without chemotherapy in subjects with advanced pancreatic cancer